Metabolic research
SLU-PP-332
Lyophilized metabolic research compound
SLU-PP-332 is an ERR-pathway research compound studied in exercise-mimetic and metabolic adaptation literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesSolo per ricerca di laboratorio. Non per uso umano o veterinario. Non destinato a diagnosticare, trattare, curare, mitigare o prevenire malattie.
Conservare sigillato, freddo, asciutto e protetto dagli sbalzi di calore. Conferma lo stoccaggio specifico del prodotto all'arrivo.
Imballato per garantire la stabilità del transito con supporto per gli ordini disponibile per le rotte con clima caldo.
Batch-linked certificate support is available through the documentation desk.
Contesto di ricerca
Profilo di ricerca SLU-PP-332
SLU-PP-332 is a small-molecule research compound associated with estrogen-related receptor signaling rather than a peptide hormone pathway. Preclinical studies use it to investigate oxidative metabolism, mitochondrial gene programs, skeletal-muscle adaptation, energy expenditure, and exercise-mimetic phenotypes. The ERR family helps regulate transcriptional networks involved in cellular energy use, so studies often measure gene expression, mitochondrial markers, endurance-related endpoints, and tissue-specific metabolic changes. This compound is best suited to mechanistic cell and animal research that specifically requires an ERR-pathway agonist. The published evidence is preclinical, and experimental findings do not establish human safety, effectiveness, or an appropriate personal-use context.
Molecular class
Synthetic estrogen-related receptor agonist
Sequence / composition
A synthetic small molecule, not a peptide; its chemical scaffold is used to probe ERR transcriptional programs.
Research design note
Research should separate direct ERR engagement from downstream mitochondrial and metabolic transcriptional responses.
Meccanismo proposto
A synthetic agonist reported to activate estrogen-related receptors, especially ERRalpha, ERRbeta, and ERRgamma. ERR activation regulates transcriptional programs involved in mitochondrial biogenesis, oxidative phosphorylation, fatty-acid oxidation, and oxidative muscle-fiber identity.
Effetti riportati negli studi
- Cell studies reported induction of ERR-regulated oxidative and mitochondrial gene programs.
- Mouse studies reported increased oxidative muscle characteristics, endurance, energy expenditure, and resistance to diet-related metabolic changes.
- The compound is a small molecule rather than a peptide, and no established human efficacy or safety profile exists.
Endpoint di ricerca comuni
ERR transcriptional activity, mitochondrial genes, oxygen consumption, fatty-acid oxidation, muscle-fiber type, exercise capacity, energy expenditure, glucose tolerance, and body composition.
Evidenze e limiti
Evidence is limited to mechanistic and animal research. Human effects, pharmacokinetics, and safety remain unestablished.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Contact support with the product name and any relevant order or batch reference to request available documents.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.